Journal Article
F. E. Taragano, Allegri, R. F., Heisecke, S. L., Martelli, M. I., Feldman, M. L., Sánchez, V., García, V. A., Tufro, G., Castro, D. M., Leguizamón, P. Perez, Guelar, V., Ruotolo, E., Zegarra, C., and Dillon, C.,
“Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”,
J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.
A. Macedo, Gómez, C., Rebelo, M. Ângelo, Poza, J., Gomes, I., Martins, S., Maturana-Candelas, A., de Pablo, V. Gutiérrez, Durães, L., Sousa, P., Figueruelo, M., Rodriguez, M., Pita, C., Arenas, M., Alvarez, L., Hornero, R., Lopes, A. M., and Pinto, N.,
“Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”,
J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
A. Macedo, Gómez, C., Rebelo, M. Ângelo, Poza, J., Gomes, I., Martins, S., Maturana-Candelas, A., de Pablo, V. Gutiérrez, Durães, L., Sousa, P., Figueruelo, M., Rodriguez, M., Pita, C., Arenas, M., Alvarez, L., Hornero, R., Lopes, A. M., and Pinto, N.,
“Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”,
J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
H. Kim, Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., and Goldberg, T. E.,
“The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.”,
J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
W. Gulisano, Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D'Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., and Arancio, O.,
“Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
W. Gulisano, Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D'Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., and Arancio, O.,
“Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C.,
“The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”,
J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
C. Cupidi, Frangipane, F., Gallo, M., Clodomiro, A., Colao, R., Bernardi, L., Anfossi, M., Conidi, M. Elena, Vasso, F., Curcio, S. Anna Maria, Mirabelli, M., Smirne, N., Torchia, G., Muraca, M. Gabriella, Puccio, G., Di Lorenzo, R., Zampieri, S., Romanello, M., Dardis, A., Maletta, R. Giovanni, and Bruni, A. Cecilia,
“Role of Niemann-Pick Type C Disease Mutations in Dementia.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
C. Cupidi, Frangipane, F., Gallo, M., Clodomiro, A., Colao, R., Bernardi, L., Anfossi, M., Conidi, M. Elena, Vasso, F., Curcio, S. Anna Maria, Mirabelli, M., Smirne, N., Torchia, G., Muraca, M. Gabriella, Puccio, G., Di Lorenzo, R., Zampieri, S., Romanello, M., Dardis, A., Maletta, R. Giovanni, and Bruni, A. Cecilia,
“Role of Niemann-Pick Type C Disease Mutations in Dementia.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
C. Cerami, Dodich, A., Greco, L., Iannaccone, S., Magnani, G., Marcone, A., Pelagallo, E., Santangelo, R., Cappa, S. F., and Perani, D.,
“The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P.,
“Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.”,
J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J.,
“Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”,
J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T.,
“Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”,
J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
B. C. M. Stephan, Birdi, R., Tang, E. Yee Hing, Cosco, T. D., Donini, L. M., Licher, S., M Ikram, A., Siervo, M., and Robinson, L.,
“Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A.,
“Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”,
J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A.,
“Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”,
J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
R. M. Wood, Garcia, Z., Daniels, N., Landon, S. M., Humayun, S., Lee, H. -gon, and Macpherson, L. J.,
“Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic Mice.”,
J Alzheimers Dis, 2020.
R. H. L. H. Rueli, Torres, D. J., Dewing, A. S. T., Kiyohara, A. C., Barayuga, S. M., Bellinger, M. T., Uyehara-Lock, J. H., White, L. R., Moreira, P. I., Berry, M. J., Perry, G., and Bellinger, F. P.,
“Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
B. M. Brown, Rainey-Smith, S. R., Doré, V., Peiffer, J. J., Burnham, S. C., Laws, S. M., Taddei, K., Ames, D., Masters, C. L., Rowe, C. C., Martins, R. N., and Villemagne, V. L.,
“Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography.”,
J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
C. LoBue, Denney, D., Hynan, L. S., Rossetti, H. C., Lacritz, L. H., Hart, J., Womack, K. B., Woon, F. L., and C Cullum, M.,
“Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.”,
J Alzheimers Dis, vol. 51, no. 3, pp. 727-36, 2016.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P.,
“Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P.,
“Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P.,
“Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
M. Javad Hajipour, Ghasemi, F., Aghaverdi, H., Raoufi, M., Linne, U., Atyabi, F., Nabipour, I., Azhdarzadeh, M., Derakhshankhah, H., Lotfabadi, A., Bargahi, A., Alekhamis, Z., Aghaie, A., Hashemi, E., Tafakhori, A., Aghamollaii, V., Mashhadi, M. Maserat, Sheibani, S., Vali, H., and Mahmoudi, M.,
“Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1187-1202, 2017.
F. H. Duits, Nilsson, J., Zetterberg, H., Blennow, K., van der Flier, W. M., Teunissen, C. E., and Brinkmalm, A.,
“Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 100, no. s1, pp. S103-S114, 2024.
] Year 